Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Coorens THH"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
Extensive heterogeneity in somatic mutation and selection in the human bladder.
Autorzy:
Lawson ARJ; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Abascal F; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Coorens THH; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Hooks Y; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
O'Neill L; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Latimer C; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Raine K; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Sanders MA; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 GD, Netherlands.
Warren AY; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
Mahbubani KTA; Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK.; NIHR Cambridge Biomedical Research Centre, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
Bareham B; Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK.; NIHR Cambridge Biomedical Research Centre, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
Butler TM; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Harvey LMR; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Cagan A; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Menzies A; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Moore L; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
Colquhoun AJ; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Turner W; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Thomas B; The Royal Melbourne Hospital, Parkville, Victoria 3010, Australia.; Department of Surgery, The University of Melbourne, Parkville, Victoria 3010, Australia.
Gnanapragasam V; Academic Urology Group, Department of Surgery and Oncology, University of Cambridge, Cambridge CB2 0QQ, UK.; Cambridge Urology Translational Research and Clinical Trials Office, University of Cambridge CB2 0QQ, UK.
Williams N; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Rassl DM; Department of Pathology, Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0AY, UK.
Vöhringer H; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton CB10 1SD, UK.
Zumalave S; Mobile Genomes and Disease, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela 15706, Spain.
Nangalia J; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Tubío JMC; Mobile Genomes and Disease, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela 15706, Spain.; Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Santiago de Compostela 15706, Spain.; The Biomedical Research Centre (CINBIO), University of Vigo, Vigo 36310, Spain.
Gerstung M; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton CB10 1SD, UK.
Saeb-Parsy K; Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK.; NIHR Cambridge Biomedical Research Centre, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
Stratton MR; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Campbell PJ; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.; Department of Haematology, University of Cambridge, Cambridge CB2 2XY, UK.
Mitchell TJ; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK.; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Martincorena I; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton CB10 1SA, UK. .
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2020 Oct 02; Vol. 370 (6512), pp. 75-82.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genes, Neoplasm*
Mutagenesis*
Selection, Genetic*
Urinary Bladder/*pathology
Urinary Bladder Neoplasms/*genetics
Urothelium/*pathology
APOBEC Deaminases/genetics ; Adult ; Aged ; Biopsy ; Chromatin Assembly and Disassembly/genetics ; Female ; Humans ; Male ; Middle Aged ; Mutagens/analysis ; Mutation
Czasopismo naukowe
Tytuł:
Embryonal precursors of Wilms tumor.
Autorzy:
Coorens THH; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Treger TD; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
Al-Saadi R; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Moore L; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Tran MGB; UCL Division of Surgery and Interventional Science, Royal Free Hospital, London NW3 2PS, UK.; Specialist Centre for Kidney Cancer, Royal Free Hospital, London NW3 2PS, UK.
Mitchell TJ; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK.
Tugnait S; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
Thevanesan C; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
Young MD; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Oliver TRW; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.
Oostveen M; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Collord G; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
Tarpey PS; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Cagan A; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Hooks Y; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Brougham M; Department of Haematology and Oncology, Royal Hospital for Sick Children, Edinburgh EH9 1LF, UK.
Reynolds BC; Department of Paediatric Nephrology, Royal Hospital for Children, Glasgow G51 4TF, UK.
Barone G; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Anderson J; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Jorgensen M; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Burke GAA; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
Visser J; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Nicholson JC; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
Smeulders N; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Mushtaq I; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Stewart GD; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK.
Campbell PJ; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Wedge DC; Big Data Institute, University of Oxford, Oxford OX3 7LF, UK.; Oxford NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Martincorena I; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Rampling D; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Hook L; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.
Warren AY; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.
Coleman N; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.
Chowdhury T; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Sebire N; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Drost J; Princess Máxima Center for Pediatric Oncology, Oncode Institute, 3584 CS Utrecht, Netherlands.
Saeb-Parsy K; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK.
Stratton MR; Wellcome Sanger Institute, Hinxton CB10 1SA, UK.
Straathof K; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Pritchard-Jones K; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Behjati S; Wellcome Sanger Institute, Hinxton CB10 1SA, UK. .; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2019 Dec 06; Vol. 366 (6470), pp. 1247-1251.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Clone Cells*
DNA Methylation*
Kidney/*pathology
Kidney Neoplasms/*genetics
Precancerous Conditions/*pathology
Wilms Tumor/*genetics
Child ; Humans ; Kidney/embryology ; Kidney Neoplasms/pathology ; Mutation ; Phylogeny ; Wilms Tumor/pathology
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies